Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2025 07:02 ET | Source: Bleichmar Fonti & Auld

MLTX STOCK NOTICE: MoonLake Immunotherapeutics Investors with Losses may have been Affected by Fraud – Contact BFA Law before December 15 Lawsuit Deadline

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
October 20, 2025 11:20 ET | Source: Berger Montague

Berger Montague PC Investigating Claims on Behalf of MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors After Class Action Filing

PHILADELPHIA, Oct. 20, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or...
October 15, 2025 11:18 ET | Source: Block & Leviton LLP

SHAREHOLDER ALERT: MoonLake Immunotherapeutics Sued For Securities Fraud by Block & Leviton LLP; December 15 Deadline To Seek To Serve As Lead Plaintiff

Block & Leviton filed a class action lawsuit today against MoonLake Immunotherapeutics (Nasdaq: MLTX). Investors should contact the firm by December 15.
October 10, 2025 08:18 ET | Source: Bleichmar Fonti & Auld

MLTX SECURITIES NOTICE: MoonLake Immunotherapeutics Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
October 08, 2025 07:36 ET | Source: Bleichmar Fonti & Auld

MLTX INQUIRY NOTICE: MoonLake Immunotherapeutics Hit with Securities Fraud Investigation Due to Drug Trial Results -- Contact BFA Law

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
October 06, 2025 14:35 ET | Source: Block & Leviton LLP

MoonLake Immunotherapeutics Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation

MoonLake Immunotherapeutics Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation.
October 06, 2025 08:36 ET | Source: Bleichmar Fonti & Auld

MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics Investigated for Securities Fraud after 90% Stock Drop – Contact BFA Law

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
October 04, 2025 07:07 ET | Source: Bleichmar Fonti & Auld

MLTX LEGAL NOTICE: MoonLake Immunotherapeutics Faces Securities Fraud Investigation due to Drug Trial Results – Contact BFA Law if You Lost Money

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
October 02, 2025 07:18 ET | Source: Bleichmar Fonti & Auld

MLTX CLASS ALERT: BFA Law Urges MoonLake Immunotherapeutics Investors to Contact the Firm about the Ongoing Securities Fraud Investigation

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
September 29, 2025 10:53 ET | Source: Block & Leviton LLP

BREAKING: MoonLake Immunotherapeutics Shares Down Over 85%; Investors Should Contact Block & Leviton to Potentially Recover Losses

Shares of MoonLake Immunotherapeutics are down over 85% today. Block & Leviton is investigating MoonLake's public statements about its drug trials.